Form NT 20-F Akso Health Group For: Mar 31

August 1, 2022 4:32 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.


Washington, D.C. 20549


FORM 12b-25




(Check one):


¨ Form 10-K    x Form 20-F    ¨ Form 11-K

¨ Form 10-Q    ¨ Form 10-D    ¨ Form N-SAR    ¨ Form N-CSR


For Period Ended: March 31, 2022


  ¨ Transition Report on Form 10-K  
  ¨ Transition Report on Form 20-F  
  ¨ Transition Report on Form 11-K  
  ¨ Transition Report on Form 10-Q  
  ¨ Transition Report on Form N-SAR  


For the Transition Period Ended:


  Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.  


If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:





Full Name of Registrant



Former Name if Applicable


Room 515, Floor 5, Jia No. 92-4 to 24 Jianguo Road, Chaoyang District
Address of Principal Executive Office (Street and Number)


Beijing 100020, People's Republic of China
City, State and Zip Code





PART II — RULES 12b-25(b) AND (c)


If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)


x (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.




State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.


Akso Health Group (the "Company") was unable to file its Annual Report on Form 20-F for the period ended March 31, 2022 on a timely basis without incurring undue hardship and expense. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company endeavors to file its Annual Report on Form 20-F no later than the fifteenth calendar day following the prescribed filing date.




(1) Name and telephone number of person to contact in regard to this notification


  Rui (Kerrie) Zhang   +(86)   10 5370 9902
  (Name)   (Area Code)   (Telephone Number)



Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s).


x Yes    ¨ No


Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?


¨ Yes    x No


If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.





Akso Health Group
(Name of Registrant as Specified in Charter)


has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.


Date: August 1, 2022 By: /s/ Rui (Kerrie) Zhang
    Rui (Kerrie) Zhang
  Title: Chief Financial Officer




Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

SEC Filings